Latest News...

Latest News & Press Release


June 24, 2014

Congratulations to Drs. Kain, Bederman, and Schwarzkopf for their exceptional contributions in the June Issue of AAOS Now, focussing on the Peri-Operative Joint Surgical Home Project at UC Irvine. Read more..

June 12, 2014

UC Irvine Health has earned The Joint Commission’s Gold Seal of Approval® for its hip and knee joint replacement programs by demonstrating compliance with the organization’s national standards for health care quality and safety in disease-specific care.

March 19, 2014

The annual meeting of the American Academy of Orthopaedic Surgeons was held from March 11 to 15 in New Orleans. The conference highlighted recent advances in the diagnosis and management of musculoskeletal conditions.

Ran Schwarzkopf, M.D., of the University of California Irvine Medical Center, and colleagues evaluated the effects of metabolic syndrome (MetS) on patients undergoing total joint replacement surgery. The investigators found that MetS produced an increased rate of short-term complications, found likely to have longer term implications because the impact of MetS on all surgical complication rates (in hospital and/or within one year post surgery) was significant.

March 05, 2014

For the second time in three years, the Orthopaedic Research & Education Foundation (OREF) has chosen one of UC Irvine Orthopaedic residents to receive their prestigious OREF Resident Clinician Scientist Training Grant. The 2014 recipient of this award is Dr. Minal Tapadia. Research grant and award recipients are selected through OREF's independent, peer-review process, supporting musculoskeletal research and education-seeking clinically relevant advancements which orthopaedic surgeons can apply in daily practice to improve their patient’s lives. The OREF grant will afford Dr. Tapadia, also a lawyer by trade, to pursue her interest as an academic orthopaedic surgeon, teaching and conducting clinical research and potentially developing new therapeutic and diagnostic techniques, which may lead to the discovery of new therapeutic agents. Dr. Tapadia defended her proposal against rigorous competition and met strict peer review standards, earning her a grant for research and innovation in orthopaedic surgery. Congratulations, Dr. Minal Tapadia, on a job well done!"

February 22, 2014

We are only 4 months until our biggest event in 2014 and need your help to find a cure.
Arthritis is the leading cause of disability and effects 53 million people.
Make a difference and sign up today

February Challenge:
First 4 new participants to sign up will
earn a $25 donation to their personal page
First 4 new team captains to sign up will
earn a $25 donation to their team page

Additional fun prizes for fundraising:
NEW! raise $250+ receive 1 meal voucher
raise $1,000+ receive 2 VIP passes to
access the the VIP Tent catered by

Congratulations to January Email campaign
winner of the Kindle Fire HDX7:
Scott Watts


2014 Walk to Cure Arthritis Committee
Event Information
Sunday, June 1, 2014
Angel Stadium, Anaheim, CA

Important Dates
Kick-Off Event
(Date has been changed)
Due to limited space, invites will be sent

Bank Day
Wednesday, May 28th
10am to 6pm
16148 Sand Canyon Ave., Irvine

2014 Honorees
Medical Honorees
Dr. Michael Fabricant
Dr. Stephen Mikulak
Dr. Ran Schwarzkopf

Youth Honoree
Karla (Lolita) Garcia

New Incentive Prize
4 Corum Watches valued at $9,000 ea
They are sporty and unisex
Individuals who raise $10,000+ will be entered into a drawing

February 14, 2014

Valentine's Day in a hospital? No problem
UC Irvine Health makes hospital room home for knee replacement patients. Read More...

February 4, 2014

OrthoBuzz: Q & A with Dr. Ran Schwarzkopf and His Experience Using Google Glass.

After reading our item about Google Glass in the January OrthoBuzz, Dr. Ran Schwarzkopf, assistant clinical professor of orthopaedics at the University of California, Irvine (UCI), wrote us to explain briefly how teams of surgeons, nurses, and anesthesiologists use the technology at UCI. Dr. Schwarzkopf kindly responded to our follow-up questions in the following interview.